Bempedoic Acid is an adenosine triphosphate-citrate lyase inhibitor used for lowering low-density lipoprotein cholesterol levels.
Bempedoic acid is a small-molecule medication that belongs to the class of cholesterol-lowering agents. It works alongside other therapies to help reduce low-density lipoprotein cholesterol (LDL-C), often referred to as “bad” cholesterol. The active ingredient is found in products such as Nexletol and in generic formulations that list bempedoic acid on the label.
In Hong Kong, the most widely recognised product containing bempedoic acid is Nexletol (tablet). Generic versions are also available, simply labelled bempedoic acid followed by the strength (for example, 180 mg tablets). These medicines are supplied as oral tablets intended for adult use. While Nexletol is marketed under its brand name, the generic tablets contain the same active ingredient and are approved by the Hong Kong Department of Health’s Pharmacy and Poisons Board.
High LDL-C (hypercholesterolaemia). Bempedoic acid is prescribed for adults whose LDL-C levels remain elevated despite a stable dose of a statin or who cannot tolerate higher-dose statins. Reducing LDL-C helps lower the risk of heart disease over time.
Familial hypercholesterolaemia. People with this inherited condition often have very high cholesterol from a young age. Adding bempedoic acid to their regimen can provide an extra reduction in LDL-C when statins alone are insufficient.
Atherosclerotic cardiovascular disease (ASCVD) risk management. For patients with established heart disease or stroke, keeping LDL-C low is a key part of long-term risk reduction. Bempedoic acid may be used as part of a broader strategy that includes lifestyle measures and other medicines.
Statin-intolerant patients. Some individuals experience muscle-related side effects from statins. Bempedoic acid offers an alternative pathway to lower cholesterol without the same muscle impact.
These are the main approved indications in Hong Kong. Use outside these areas should be discussed with a qualified health professional.
Bempedoic acid blocks a specific step in the liver’s cholesterol-making process, leading to a decrease in the amount of LDL-C released into the bloodstream. Because it is activated only in the liver, it does not affect muscle tissue, which explains the lower incidence of muscle-related complaints compared with some other cholesterol medicines. The cholesterol-lowering effect can be seen within a few weeks of consistent use.
These reactions are generally transient and do not require medical intervention unless they persist.
If any of these signs appear, immediate medical assistance is warranted.
For a full list of interactions, refer to the prescribing information associated with each specific product.
Store tablets at room temperature, away from excess moisture and direct sunlight. Keep them out of reach of children. Treatment duration varies; some patients use bempedoic acid for a few months to achieve target cholesterol levels, while others may continue long-term under professional supervision. Because strengths and combination products differ, always follow the instructions that accompany the particular medication you have.
For detailed usage, dosing, and administration, refer to the information supplied with your specific bempedoic acid product.
This article offers general educational information about bempedoic acid as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing bempedoic acid may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
